Malignant effusion of chromophobe renal-cell carcinoma: Cytological and immunohistochemical findings

Diagnostic Cytopathology

Volumn 40, Issue 1, 2012, Pages 56-61

  Teresa, Pusiol ^a   Maria Grazia, Zorzi ^a   Doriana, Morichetti ^a   Irene, Piscioli ^b   Michele, Scialpi ^c  

^a Rovereto Hospital   (Italy)

^b Budrio Hospital   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

Author keywords

chromophobe renal cell carcinoma; immunohistochemistry; malignant pleural effusion

Indexed keywords

CALRETININ; CYTOKERATIN; PARVALBUMIN; PODOPLANIN; SUNITINIB; THYROID TRANSCRIPTION FACTOR 1; UVOMORULIN;

ABDOMINAL PAIN; AGED; ARTICLE; CASE REPORT; COUGHING; CYTOLOGY; FEVER; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AGED; CARCINOMA, RENAL CELL; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; PLEURAL EFFUSION, MALIGNANT;

EID: 84055192607     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21599     Document Type: Article

References (36)

1. Sears D, Hajdu SI,. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. Acta Cytol 1987; 31: 85-97. (Pubitemid 17050047)
2. Spieler P, Gloor F,. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies. Acta Cytol 1985; 29: 753-767. (Pubitemid 16225797)
3. Murphy WM, Ng AB,. Determination of primary site by examination of cancer cells in body fluids. Am J Clin Pathol 1972; 58: 479-488.
4. Chernow B, Sahn SA,. Carcinomatous involvement of the pleura: An analysis of 96 patients. Am J Med 1977; 63: 695-702. (Pubitemid 8222934)
5. Saitoh H,. Distant metastasis of renal adenocarcinoma. Cancer 1981; 48: 1487-1491. (Pubitemid 11042605)
6. Renshaw AA, Comiter CV, Nappi D, Granter SR,. Effusion cytology of renal cell carcinoma. Cancer 1998; 84: 148-152. (Pubitemid 28299757)
7. Bannasch P, Schacht U, Storch E,. [Morphogenesis and micromorphology of epithelial tumors of the kidney of nitrosomorpholine intoxicated rats. I. Induction and histology]. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 1974; 81: 311-331.
8. Thoenes W, Störkel S, Rumpelt HJ,. Human chromophobe cell renal carcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol 1985; 48: 207-217. (Pubitemid 15095927)
9. Thoenes W, Störkel S, Rumpelt HJ,. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 1986; 181: 125-143. (Pubitemid 16021498)
10. Akhtar M, Chantziantoniou N,. Flow cytometric and quantitative image cell analysis of DNA ploidy in renal chromophobe cell carcinoma. Hum Pathol 1998; 29: 1181-1188. (Pubitemid 28525515)
11. Amin MB, Amin MB, Tamboli P, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: An experience of 405 cases. Am J Surg Pathol 2002; 26: 281-291. (Pubitemid 34184451)
12. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML,. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003; 27: 612-624. (Pubitemid 36514472)
13. Crotty TB, Farrow GM, Lieber MM,. Chromophobe cell renal carcinoma: Clinicopathological features of 50 cases. J Urol 1995; 154: 964-967.
14. Renshaw AA, Henske EP, Loughlin KR, Shapiro C, Weinberg DS,. Aggressive variants of chromophobe renal cell carcinoma. Cancer 1996; 78: 1756-1761. (Pubitemid 26330904)
15. Martignoni G, Pea M, Chilosi M, et al. Parvalbumin is constantly expressed in chromophobe renal carcinoma. Mod Pathol 2001; 14: 760-767. (Pubitemid 33069834)
16. Abrahams NA, MacLennan GT, Khoury JD, et al. Chromophobe renal cell carcinoma: A comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology 2004; 45: 593-602. (Pubitemid 40029819)
17. Kim MK, Kim S,. Immunohistochemical profile of common epithelial neoplasms arising in the kidney. Appl Immunohistochem Mol Morphol 2002; 10: 332-338. (Pubitemid 35453692)
18. Skinnider BF, Folpe AL, Hennigar RA, et al. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: Potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am J Surg Pathol 2005; 29: 747-754. (Pubitemid 40734424)
19. Martignoni G, Pea M, Brunelli M, et al. CD10 is expressed in a subset of chromophobe renal cell carcinomas. Mod Pathol 2004; 17: 1455-1463. (Pubitemid 39627071)
20. Langner C, Wegscheider BJ, Ratschek M, Schips L, Zigeuner R,. Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: A systematic analysis of 233 tumors. Virchows Arch 2004; 444: 127-134. (Pubitemid 38315289)
21. Taki A, Nakatani Y, Misugi K, Yao M, Nagashima Y,. Chromophobe renal cell carcinoma: An immunohistochemical study of 21 Japanese cases. Mod Pathol 1999; 12: 310-317. (Pubitemid 29133853)
22. Yamazaki K, Sakamoto M, Ohta T, Kanai Y, Ohki M, Hirohashi S,. Overexpression of KIT in chromophobe renal cell carcinoma. Oncogene 2003; 13: 22: 847-852. (Pubitemid 36255820)
23. Avery AK, Beckstead J, Renshaw AA, Corless CL,. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 2000; 24: 203-210. (Pubitemid 30078709)
24. McGregor DK, Khurana KK, Cao C, et al. Diagnosing primary and metastatic renal cell carcinoma: The use of the monoclonal antibody 'renal cell carcinoma marker'. Am J Surg Pathol 2001; 25: 1485-1492. (Pubitemid 33096962)
25. Tretiakova MS, Sahoo S, Takahashi M, et al. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol 2004; 28: 69-76. (Pubitemid 38031623)
26. Rocca PC, Brunelli M, Gobbo S, et al. Diagnostic utility of S100A1 expression in renal cell neoplasms: An immunohistochemical and quantitative RT-PCR study. Mod Pathol 2007; 20: 722-728. (Pubitemid 46933453)
27. Li G, Barthelemy A, Feng G, et al. S100A1: A powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma. Histopathology 2007; 50: 642-647. (Pubitemid 46495825)
28. Mazal PR, Stichenwirth M, Koller A, et al. Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: A tissue microarray study. Mod Pathol 2005; 18: 535-540. (Pubitemid 40478117)
29. Memeo L, Jhang J, Assaad AM, et al. Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: Value in the differential diagnosis of chromophobe cell carcinoma. Am J Clin Pathol 2007; 127: 225-229. (Pubitemid 46797179)
30. Ozcan A, Zhai J, Hamilton C, et al. PAX-2 in the diagnosis of primary renal tumors: Immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin. Am J Clin Pathol 2009; 131: 393-404.
31. Daniel L, Lechevallier E, Giorgi R, et al. PAX-2 expression in adult renal tumors. Hum Pathol 2001; 32: 282-287. (Pubitemid 32246801)
32. Zhou M, Roma A, Magi-Galluzzi C,. The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms. Clin Lab Med 2005; 25: 247-257. (Pubitemid 40545818)
33. Leroy X, Moukassa D, Copin MC, Saint F, Mazeman E, Gosselin B,. Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma. Eur Urol 2000; 37: 484-487. (Pubitemid 30157812)
34. Mathers ME, Pollock AM, Marsh C, O'Donnell M,. Cytokeratin 7: A useful adjunct in the diagnosis of chromophobe renal cell carcinoma. Histopathology 2002; 40: 563-567. (Pubitemid 34621815)
35. Wu SL, Kothari P, Wheeler TM, Reese T, Connelly JH,. Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas. Mod Pathol 2002; 15: 712-717. (Pubitemid 34787306)
36. Khoury JD, Abrahams NA, Levin HS, MacLennan GT,. The utility of epithelial membrane antigen and vimentin in the diagnosis of chromophobe renal cell carcinoma. Ann Diagn Pathol 2002; 6: 154-158. (Pubitemid 34700852)